DAEWOONG PHARMA
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
069620 | KO
Overview
Corporate Details
- ISIN(s):
- KR7069620003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단4길 35-14, 화성시
- Sector:
- Manufacturing
Description
Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-14 00:00 |
자기주식처분결과보고서
|
Korean | 17.1 KB | ||
| 2023-03-14 00:00 |
최대주주등소유주식변동신고서
|
Korean | 30.8 KB | ||
| 2023-03-13 00:00 |
불성실공시법인지정
|
Korean | 7.8 KB | ||
| 2023-03-09 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 79.8 KB | ||
| 2023-03-09 00:00 |
[기재정정]주요사항보고서(자기주식처분결정)
|
Korean | 29.5 KB | ||
| 2023-03-08 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 26.7 KB | ||
| 2023-03-08 00:00 |
감사보고서제출
|
Korean | 19.2 KB | ||
| 2023-03-08 00:00 |
주주총회소집결의
|
Korean | 12.1 KB | ||
| 2023-03-08 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.5 KB | ||
| 2023-02-24 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 8.0 KB | ||
| 2023-02-23 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.5 KB | ||
| 2023-02-17 00:00 |
투자판단관련주요경영사항(<보툴리눔 균주 및 독소제제 제조기술정보의 사용금지 및 손해배상청구>에 대한 강제집행정지신청 인용)
|
Korean | 7.4 KB | ||
| 2023-02-15 00:00 |
소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 10.7 KB | ||
| 2023-02-15 00:00 |
소송등의판결ㆍ결정(일정금액이상의청구)
|
Korean | 10.8 KB | ||
| 2023-02-15 00:00 |
[기재정정]소송등의판결ㆍ결정(일정금액이상의청구)
|
Korean | 14.8 KB |
Automate Your Workflow. Get a real-time feed of all DAEWOONG PHARMA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DAEWOONG PHARMA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWOONG PHARMA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
